Sinovac, a leading global biopharmaceutical company, hosted its "Sinovac Open Day for International Media" event on Friday, welcoming journalists from around 30 countries.

The event provided an in-depth look at Sinovac’s operations and ongoing global initiatives aimed at advancing public health.

The programme began with a welcome speech from Pearson Liu, Senior Assistant to the Chief Business Officer of Sinovac Holding Group Co., Ltd.

In his address, Liu highlighted the company’s commitment to innovation, global partnerships, and the development of life-saving vaccines.

He emphasised Sinovac’s role in combating global health challenges, underscoring its dedication to improving health outcomes worldwide.

Ying Zhang, Deputy General Manager of Sinovac Life Science Co., Ltd., also spoke at the event, offering insights into the company’s research and development strategies, particularly focusing on vaccine production and distribution.

Zhang outlined the company’s international collaborations and its mission to provide accessible, effective healthcare solutions globally.

Replying to a question about the quality and safety of vaccines delivered to countries like Bangladesh during the COVID-19 pandemic, Perry Peng, Country Business Development Manager of Sinovac's International Department, said Sinovac ensures the highest standards of quality and safety for every country it serves.

"This commitment applies not only to Bangladesh but to all the countries we supply vaccines to. Sinovac never compromises on safety or quality," Peng added, reaffirming the company's dedication to global health and vaccine integrity.

A key highlight of the event was a visit to the “Vaccine & Hope” exhibition hall, where journalists explored Sinovac's history, achievements, and its contributions to global health.

The exhibition showcased the company’s extensive work in developing vaccines for a wide range of infectious diseases, emphasizing the impact of vaccination in preventing global health crises.

The journalists also toured the Influenza Vaccine Workshop, where they gained insights into Sinovac’s state-of-the-art production processes for influenza vaccines.

The workshop provided a behind-the-scenes look at how Sinovac ensures the safety, efficacy, and quality of its vaccines, while also highlighting the company's commitment to addressing seasonal flu outbreaks worldwide.

The event provided an opportunity for foreign journalists to engage with Sinovac leaders and gain a deeper understanding of the company’s pivotal role in global health.

The open day also featured interactive sessions and a tour of Sinovac’s cutting-edge facilities, offering a firsthand look at the company’s state-of-the-art manufacturing processes.